Atherogenic Impact of Homocysteine: Can HMG-CoA Reductase Inhibitors Additionally Influence Hyperhomocysteinaemia?

Atherogenic Impact of Homocysteine: Can HMG-CoA Reductase Inhibitors Additionally Influence Hyperhomocysteinaemia?

The strong association among the risk of coronary artery diseases (CAD), high levels of LDL-C and low levels of HDLC is well established. Hyperhomocysteinaemia (HHcy) is an independent risk factor for cardiovascular disease (CVD) and causes endothelial dysfunction, a hallmark of atherosclerosis. In...

Full description

Bibliographic Details
Main Authors: Nikolic Tamara, Srejovic Ivan, Stojic Isidora, Jeremic Jovana, Folic Marko, Matic Stevan, Rakocevic Milena, Jancic Snezana, Jakovljevic Biljana, Obrenovic Radmila, Djuric Dusan, Zivkovic Vladimir
Format: Article
Language:English
Published: Sciendo 2019-06-01
Series:Serbian Journal of Experimental and Clinical Research
Subjects:
atherogenic index
hyperhomocysteinaemia
liver
hmg-coa reductase inhibitors
Online Access:https://doi.org/10.1515/sjecr-2017-0055

Internet

https://doi.org/10.1515/sjecr-2017-0055

Similar Items